Pulse Biosciences, Inc. (NASDAQ:PLSE – Get Free Report)’s stock price gapped up prior to trading on Friday . The stock had previously closed at $15.66, but opened at $16.36. Pulse Biosciences shares last traded at $16.13, with a volume of 55,647 shares trading hands.
Wall Street Analysts Forecast Growth
Separately, StockNews.com raised Pulse Biosciences to a “sell” rating in a research report on Thursday, January 2nd.
View Our Latest Stock Analysis on PLSE
Pulse Biosciences Price Performance
Institutional Inflows and Outflows
Several institutional investors and hedge funds have recently made changes to their positions in the stock. Tower Research Capital LLC TRC grew its position in Pulse Biosciences by 98.1% during the fourth quarter. Tower Research Capital LLC TRC now owns 1,692 shares of the company’s stock worth $29,000 after buying an additional 838 shares in the last quarter. KLP Kapitalforvaltning AS bought a new stake in shares of Pulse Biosciences in the 4th quarter worth approximately $44,000. Caisse Des Depots ET Consignations acquired a new stake in shares of Pulse Biosciences during the 4th quarter worth approximately $95,000. Farther Finance Advisors LLC increased its position in shares of Pulse Biosciences by 44.4% during the fourth quarter. Farther Finance Advisors LLC now owns 7,220 shares of the company’s stock valued at $126,000 after purchasing an additional 2,220 shares during the period. Finally, SG Americas Securities LLC acquired a new position in shares of Pulse Biosciences in the fourth quarter valued at $193,000. Institutional investors own 76.95% of the company’s stock.
Pulse Biosciences Company Profile
Pulse Biosciences, Inc operates as a novel bioelectric medicine company. The company offers CellFX System, a tunable, software-enabled, and console-based platform that delivers nano second duration pulses of electrical energy to non-thermally clear targeted cells while sparing adjacent non-cellular tissue to treat a various medical condition by using its Nano-Pulse Stimulation technology.
See Also
- Five stocks we like better than Pulse Biosciences
- Quiet Period Expirations Explained
- JPMorgan: The ‘NVIDIA of Banking’ Poised for More Gains?
- Where Do I Find 52-Week Highs and Lows?
- Buy the Chewy Stock Reversal? Here’s Why Now Is the Time
- Bank Stocks – Best Bank Stocks to Invest In
- Ibotta Stock: Why the Buyback Looks Like a Bullish Bet
Receive News & Ratings for Pulse Biosciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Pulse Biosciences and related companies with MarketBeat.com's FREE daily email newsletter.